SH2D3A
SH2 domain-containing protein 3A
Also known as: NSP1, SH23A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BRG2
- Gene
- SH2D3A
- Ensembl
- ENSG00000125731
- Chromosome
- 19
- Canonical length
- 576 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Microtubules,Cytokinetic bridge
OverviewNCBI Gene
Predicted to enable guanyl-nucleotide exchange factor activity and phosphotyrosine residue binding activity. Predicted to be involved in JNK cascade. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
576 residues, UniProt reviewed canonical sequence.
>Q9BRG2|SH2D3A
1 MQVPQDGEDL AGQPWYHGLL SRQKAEALLQ QNGDFLVRAS GSRGGNPVIS CRWRGSALHF
61 EVFRVALRPR PGRPTALFQL EDEQFPSIPA LVHSYMTGRR PLSQATGAVV SRPVTWQGPL
121 RRSFSEDTLM DGPARIEPLR ARKWSNSQPA DLAHMGRSRE DPAGMEASTM PISALPRTSS
181 DPVLLKAPAP LGTVADSLRA SDGQLQAKAP TKPPRTPSFE LPDASERPPT YCELVPRVPS
241 VQGTSPSQSC PEPEAPWWEA EEDEEEENRC FTRPQAEISF CPHDAPSCLL GPQNRPLEPQ
301 VLHTLRGLFL EHHPGSTALH LLLVDCQATG LLGVTRDQRG NMGVSSGLEL LTLPHGHHLR
361 LELLERHQTL ALAGALAVLG CSGPLEERAA ALRGLVELAL ALRPGAAGDL PGLAAVMGAL
421 LMPQVSRLEH TWRQLRRSHT EAALAFEQEL KPLMRALDEG AGPCDPGEVA LPHVAPMVRL
481 LEGEEVAGPL DESCERLLRT LHGARHMVRD APKFRKVAAQ RLRGFRPNPE LREALTTGFV
541 RRLLWGSRGA GAPRAERFEK FQRVLGVLSQ RLEPDRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SH2D3A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 31 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 31 nTPM
- skin: 27 nTPM
- pancreas: 19 nTPM
- salivary gland: 18 nTPM
- prostate: 18 nTPM
- kidney: 17 nTPM
Single-cell type
- esophageal apical cells: 156 nCPM
- urothelial cells: 114 nCPM
- extravillous trophoblasts: 86 nCPM
- esophageal suprabasal cells: 72 nCPM
- alveolar cells type 1: 69 nCPM
- pancreatic duct cells: 68 nCPM
Immune cell
- naive CD4 T-cell: 7.7 nTPM
- memory CD4 T-cell: 5.9 nTPM
- naive B-cell: 5.6 nTPM
- memory CD8 T-cell: 5.2 nTPM
- MAIT T-cell: 4.2 nTPM
- naive CD8 T-cell: 4.2 nTPM
Brain region
- cerebral cortex: 2.6 nTPM
- choroid plexus: 2.3 nTPM
- white matter: 2.3 nTPM
- medulla oblongata: 2.1 nTPM
- thalamus: 1.9 nTPM
- pons: 1.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.03
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.05
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SH2D3A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SH2D3A as an antibody target. Whether an autoantibody or antibody against SH2D3A could matter depends on whether native SH2D3A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SH2D3A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SH2D3A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...